During the past decade, K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Pharmazz, Inc." with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Asahi Kasei Pharma America Corporation" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre" are "Hypovolemic Shock" (2 trials), "Acute Spinal Cord Injury" (1 trials), "Adenoviral Conjunctivitis" (1 trials), "Blood Loss" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre" in a lesser frequency.

Most popular intervention types in "K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre" are "Drug" (15 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Darolutamide (Nubeqa, BAY1841788)" (2 trials), "Etrolizumab" (2 trials), "ART-123" (1 trials) and "Androgen deprivation therapy (ADT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre" are 12 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".